Loading...
XKLS
5168
Market cap960mUSD
Apr 24, Last price  
1.15MYR
Name

Hartalega Holdings Berhad

Chart & performance

D1W1MN
XKLS:5168 chart
P/E
38.10
P/S
1.84
EPS
0.03
Div yield, %
0.30%
Shrs. gr., 5y
-0.04%
Rev. gr., 5y
-20.45%
Revenues
2.14b
-17.41%
240,915,000240,915,000443,204,278571,892,668734,920,894931,064,7041,032,035,6871,107,079,3651,145,960,4221,498,336,6381,821,873,3532,405,638,1062,827,218,4102,924,313,6036,703,485,0007,888,286,0002,409,618,0001,838,110,0002,585,649,0002,135,435,000
Net income
103m
+38.20%
37,013,00037,013,00084,511,049142,908,975190,296,590201,380,287233,336,229232,813,348209,732,833257,427,543283,001,350438,919,102455,177,921433,618,0002,885,513,0003,234,453,000-235,136,00012,501,00074,542,000103,017,000
CFO
352m
+209.02%
60,770,77383,801,464163,926,406184,822,182200,342,170317,567,563248,855,647206,535,710239,496,535336,753,369403,949,330627,398,517655,724,1403,088,180,0003,716,403,000-36,762,000-8,646,000113,832,000351,765,000
Dividend
May 19, 20260.018 MYR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Hartalega Holdings Berhad operates as an investment holding enterprise with a primary focus on the global manufacturing, distribution, and sale of latex and nitrile gloves. Its extensive market reach spans Malaysia, North America, Europe, various regions of Asia, Australia, South America, and the Middle East. Additionally, the company diversifies its operations through property leasing, pioneering research and development in automation systems, and the international export and trade of medical supplies. Its product offerings cater to a wide array of industries, including healthcare, dentistry, food processing, industrial use, veterinary care, and the spa and beauty salon sectors. The company was established in 1988 and maintains its headquarters in Kuala Lumpur, Malaysia.
URL
https://hartalega.com.my/
IPO date
Apr 17, 2008
Employees
Domiciled in
MY
Incorporated in
MY

Valuation

Title
MYR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT